Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

UBXG vs GSUN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GSUN Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 5–3 Matrix Metrics)

GSUN Overall Winner 6-Pillar Tally: UBXG 0 – 4 GSUN (2 Tie) Matrix Metrics: UBXG 3 – 5 GSUN

As of Nov 20, 2026, Golden Sun Health Technology Group Limited Class A (GSUN) is the stronger overall head-to-head candidate over U-BX Technology Ltd. (UBXG) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). UBXG carries a Unified Composite Score of 48.9/100 (HOLD) at $5.03 (N/M Forward P/E, -87.6% operating margin), whereas GSUN carries 40.3/100 (SELL) at $0.12 (N/M Forward P/E, -10.2% operating margin).

  • Composite vs. Pillar Nuance: While UBXG currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. GSUN 40.3/100 SELL), GSUN captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-10.2% vs. -87.6% operating margin) and revenue trajectory (+30.1% vs. -32.6% YoY).
  • Technical & Structure Timing Caution: UBXG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9); meanwhile GSUN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UBXG vs GSUN
UBXG NASDAQ
U-BX Technology Ltd. Ordinary Shares
Services-Computer Programming, Data Processing, Etc.
$5.03
-0.2% 1D
Market Cap $9.2M
TTM Revenue $24M
Forward P/E N/M
Beta / 30D Vol 10.23β · 225% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 48.9 · SMA20: $5.96 · SMA50: $4.05
GSUN NASDAQ Head-to-Head Winner
Golden Sun Health Technology Group Limited Class A Ordinary Shares
Services-Educational Services
$0.12
-7.01% 1D
Market Cap $1.3M
TTM Revenue $40M
Forward P/E N/M
Beta / 30D Vol 0.59β · 59% Vol
Unified Composite Score
40.3 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.6%), weak momentum, RSI 24
RSI-14: 24.1 · SMA20: $0.16 · SMA50: $0.20

6-Pillar Scorecard Institutional Category Breakdown (UBXG 0 – 4 GSUN)

Columns: Metric · UBXG · GSUN
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M 0.3x
PEG Ratio N/M N/M
EV / Revenue 0.4x N/M
2. Growth & Scale GSUN
Revenue Growth (YoY) -32.6% +30.1%
Earnings Growth (YoY) -88.4% -73.7%
TTM Revenue (USD) $24M $40M
Market Cap $9.2M $1.3M
3. Profitability & Quality GSUN
Gross Margin 0.3% 1.8%
Operating Margin -87.6% -10.2%
Net Profit Margin -55.1% -9.8%
Return on Equity (ROE) -46.6% -247.2%
4. Balance Sheet & Cash Flow GSUN
Cash Generation (TTM) -$13M EBITDA -$4.0M EBITDA
Cash Flow Margin -53.4% EBITDA Mgn -9.8% EBITDA Mgn
Net Cash / Leverage $30.52 Book/Sh · -46.6% ROE $0.73 Book/Sh · -247.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat GSUN
OpEx & R&D Intensity N/A 12.0% of Rev ($4.9M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Advertising Agencies Operator Education & Training Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UBXG (3) vs GSUN (5)
Institutional Metric UBXG GSUN Criterion Row Edge
Market Capitalization
Scale
$9.2M $1.3M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M 0.3x Lower Multiple GSUN
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-32.6% +30.1% Higher Growth GSUN
Operating Margin (TTM)
Profitability
-87.6% -10.2% Higher Margin GSUN
Net Profit Margin
Profitability
-55.1% -9.8% Higher Margin GSUN
Return on Equity (ROE)
Capital Efficiency
-46.6% -247.2% Higher ROE UBXG
52-Week Range Position
Momentum
38% ($0–$13) 1% ($0–$2) Stronger Trend UBXG
Beta / 30D Volatility
Risk Regime
10.23β · 225% Vol 0.59β · 59% Vol Lower Realized Risk GSUN
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 40.3 / 100 (SELL) Higher Composite UBXG
Trailing 12M Revenue (USD)
Operating Scale
$24M $40M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
0.3% 1.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$13M EBITDA ($30.52 Book/Sh · -46.6% ROE) -$4.0M EBITDA ($0.73 Book/Sh · -247.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GSUN +12.17 pp
UBXG: -48.14% · GSUN: -35.97%
3M Horizon UBXG +405.13 pp
UBXG: +379.05% · GSUN: -26.08%
6M Horizon UBXG +242.35 pp
UBXG: +164.74% · GSUN: -77.61%
1Y Horizon UBXG +219.31 pp
UBXG: +139.52% · GSUN: -79.79%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UBXG vs GSUN. Trailing 12-month operating profitability (UBXG -87.6% vs GSUN -10.2%) and valuation multiples (UBXG N/M vs GSUN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

UBXG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$24M
Gross Margin0.3%
Op. Margin-87.6%
ROE / Fwd P/E-46.6% · N/M
GSUN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$40M
Gross Margin1.8%
Op. Margin-10.2%
ROE / Fwd P/E-247.2% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UBXG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact UBXG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GSUN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GSUN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UBXG Moat Profile Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $9.2M market capitalization and -87.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GSUN Moat Profile Cyclical / Execution-Driven Positioning
Education & Training Services Operator
Competes within the Education & Training Services value chain with $1.3M market capitalization and -10.2% operating margin.
OpEx & R&D Reinvestment 12.0% of Rev ($4.9M)
90D Engineering Disclosures 0 Published

Investor FAQ UBXG vs GSUN Key Questions & Quantitative Answers

As of Nov 20, 2026, Golden Sun Health Technology Group Limited Class A (GSUN) is the stronger overall head-to-head candidate over U-BX Technology Ltd. (UBXG) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). UBXG carries a Unified Composite Score of 48.9/100 (HOLD) at $5.03 (N/M Forward P/E, -87.6% operating margin), whereas GSUN carries 40.3/100 (SELL) at $0.12 (N/M Forward P/E, -10.2% operating margin). Composite vs. Pillar Nuance: While UBXG currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. GSUN 40.3/100 SELL), GSUN captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-10.2% vs. -87.6% operating margin) and revenue trajectory (+30.1% vs. -32.6% YoY). Technical & Structure Timing Caution: UBXG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.9); meanwhile GSUN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GSUN leads the Growth & Scale pillar: UBXG posts -32.6% YoY revenue growth and -88.4% YoY earnings growth on $24M TTM revenue (0.3% gross margin, -87.6% operating margin), compared with GSUN at +30.1% YoY revenue growth and -73.7% YoY earnings growth on $40M TTM revenue (1.8% gross margin, -10.2% operating margin). On trailing 12-month operating scale, UBXG generates $24M in USD-normalized revenue versus $40M for GSUN. In operating R&D and SG&A reinvestment, UBXG deploys N/A (0 90-day corporate R&D disclosures) versus 12.0% of Rev ($4.9M) (0 disclosures) for GSUN.

UBXG and GSUN trade at balanced relative valuation multiples. UBXG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (-53.4% EBITDA margin), whereas GSUN trades at N/M Forward P/E, 0.3x Trailing P/E, N/M PEG, and N/M EV/Revenue (-9.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UBXG (-46.6% ROE) versus GSUN (-247.2% ROE) capital efficiency.

In options market volatility and institutional positioning, UBXG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (10.23β · 225% Vol realized risk). By comparison, GSUN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 59% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.